Biotechnology

Governor, Senate President, Speaker Head to BIO International Convention with Cutting-Edge Life Sciences Law in Hand

BOSTON– Monday June 16, 2008 – Massachusetts Governor Deval Patrick, joined by Senate President Therese Murray and Speaker of the House Salvatore F. DiMasi, signed pioneering legislation today at the Joslin Diabetes Center that will secure Massachusetts’ position as a global leader in life sciences, unveiling for the first time the comprehensive, innovative Massachusetts Life Sciences Law.    » read more »

15 January 2008 -- A final report from the U.S. Food and Drug Administration concludes that meat and milk from cloned cows, pigs, goats and their offspring are safe for American consumers to eat and drink. Opponents, including a number of consumer and animal rights groups, say the FDA was heavily influenced by the biotechnology industry, and failed to consider possible side effects of cloning.    » read more »

Cold Spring Harbor Laboratory to add 80 jobs to Long Island's Innovation Economy

January 11, 2008 -- In a visit to Long Island as part of his statewide tour following his State of the State address, New York Governor Eliot Spitzer today announced a $2 million economic development grant to assist Cold Spring Harbor Laboratory. The grant will help Cold Spring Harbor Laboratory purchase new equipment for its new $200 million Hillside research complex, creating 80 high tech jobs over the next three years.    » read more »

Oregon’s Vaccine and Gene Therapy Institute to expand to Florida biotech hub

January 8, 2008 -- PORT ST. LUCIE – Florida Governor Charlie Crist today announced the expansion of the Oregon Health and Science University’s Vaccine and Gene Therapy Institute (VGTI) to Port St. Lucie. The Florida program will focus its research efforts on understanding and treating infection, immunity and inflammation in older adults. VGTI has assembled expertise to allow the rapid movement of discoveries from the laboratory to the clinic for use as medical treatments.    » read more »

Single Company for Amgen Products in New Arrangement

ZUG, Switzerland. (Oct. 4, 2007) -- Amgen, the world's largest biotechnology company and Dompe Biotec, S.p.A., its co-marketing partner in Italy, announced today that they have agreed to combine their current commercial operations with respect to Amgen products under a single company to be called Amgen-Dompe S.p.A.

Based in Milan, Amgen-Dompe will be organised as an Amgen affiliate and comprise current Amgen and Dompe staff plus current Amgen R&D staff in Italy.    » read more »

Sept. 4, 2007, LAWRENCE — The Osher Lifelong Learning Institute at the University of Kansas will offer 21 courses and three special events this fall in Lawrence and Topeka, as well as its new locations in Overland Park and Clay County in Missouri.    » read more »

August 27, 2007 -- Kentucky Attorney General Greg Stumbo filed comments today asking the U.S. District Court in Washington, D.C. to reject a proposed consent decree that would approve Monsanto Company’s acquisition of Delta & Pine Land Company.

General Stumbo noted in the filing that this acquisition will “eliminate competition in agriculture biotechnology and seeds, stifle innovation and product choice, and result in higher prices to U.S. farmers and consumers.”    » read more »